Conducted study on Flexovital at a Swedish university.
Flexovital+N.O.RDIC is based on the Nobel Prize-winning discovery of the nitric oxide molecule, a discovery that led to new blood pressure and heart medications. When we conducted our initial animal study, our goal was to demonstrate that Flexovital has protective effects on blood vessels and the heart, as well as a positive effect on blood pressure.
Exceeded expectations!
Last year, we conducted a three-month study (using a specially designed animal model) to determine whether Flexovital+N.O.RDIC could provide protection against organ damage associated with Western junk food diets, obesity, and type 2 diabetes. The results exceeded our expectations, showing multiple vital health benefits:
Results
Reduced weight gain (22%):
One of the most impressive findings was a 22% reduction in weight gain in the group receiving Flexovital+N.O.RDIC compared to the control group. This suggests that Flexovital+N.O.RDIC may effectively support weight control.
Improved kidney function by 75%:
The group receiving Flexovital exhibited significantly improved kidney function (kidney filtration improved by 75%) compared to those not receiving the product.
Protective effects on the heart and blood vessels:
Flexovital+N.O.RDIC showed strong protective effects on the heart and blood vessels. In the group that did not receive Flexovital, Troponin levels increased by 250%, whereas in the Flexovital group, the increase was 0%.
Additional effects:
Blood sugar levels improved, and inflammation was reduced
